Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study

By sjmartinez • September 11, 2024

Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa N, Sauter W, McShane PJ. Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2024 Sep 10:2401551. doi: 10.1183/13993003.01551-2024. Epub ahead of print. PMID: 39255990.

Tags: Dermatology, Publications

Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board

Blauvelt A, Prussick R, Merola JF, Shahriari M, Cather J, Eakin GS, McCormick Howard L, Lebwohl MG, Armstrong AW, Duffin KC. Clarifying Psoriasis Disease Severity:[...]

Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management

Peng DS, Shen A, Kang Y, Yamamoto RK, Levins P. Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management. Cureus.[...]

Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database

Kasperkiewicz M, Ludwig RJ, Curman P. Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database.[...]